E. Q. Lee

843 total citations
8 papers, 574 citations indexed

About

E. Q. Lee is a scholar working on Genetics, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, E. Q. Lee has authored 8 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 5 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in E. Q. Lee's work include Glioma Diagnosis and Treatment (7 papers), Brain Metastases and Treatment (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). E. Q. Lee is often cited by papers focused on Glioma Diagnosis and Treatment (7 papers), Brain Metastases and Treatment (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). E. Q. Lee collaborates with scholars based in United States and Switzerland. E. Q. Lee's co-authors include David A. Reardon, Patrick Y. Wen, W.K. Alfred Yung, Keith L. Ligon, Andrew D. Norden, Patrick Y Wen, D. Schiff, Lakshmi Nayak, Mikael L. Rinne and A. S. and has published in prestigious journals such as Neuro-Oncology and Journal of Neuro-Oncology.

In The Last Decade

E. Q. Lee

8 papers receiving 558 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. Q. Lee United States	8	325	245	124	111	108	8	574
Akiyoshi Ogino Japan	15	215 0.7×	199 0.8×	95 0.8×	105 0.9×	99 0.9×	33	533
Sigmund Hsu United States	9	318 1.0×	160 0.7×	88 0.7×	83 0.7×	116 1.1×	26	498
Eric Burton United States	14	404 1.2×	207 0.8×	148 1.2×	104 0.9×	186 1.7×	41	784
Ralf Ketter Germany	12	286 0.9×	97 0.4×	87 0.7×	193 1.7×	48 0.4×	25	515
Yoshie Yasui Japan	11	211 0.6×	155 0.6×	104 0.8×	49 0.4×	85 0.8×	19	408
Christine Lu‐Emerson United States	8	234 0.7×	169 0.7×	119 1.0×	75 0.7×	126 1.2×	19	551
Antonino Rotilio Italy	12	344 1.1×	112 0.5×	62 0.5×	148 1.3×	35 0.3×	18	562
Chiaki Komine Japan	13	287 0.9×	280 1.1×	133 1.1×	49 0.4×	68 0.6×	29	570
João N. Stávale Brazil	12	279 0.9×	104 0.4×	50 0.4×	51 0.5×	65 0.6×	23	538
Takakazu Yokoyama Japan	10	215 0.7×	209 0.9×	81 0.7×	64 0.6×	69 0.6×	17	466

Countries citing papers authored by E. Q. Lee

Since Specialization

Citations

This map shows the geographic impact of E. Q. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Q. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Q. Lee more than expected).

Fields of papers citing papers by E. Q. Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Q. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Q. Lee. The network helps show where E. Q. Lee may publish in the future.

Co-authorship network of co-authors of E. Q. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of E. Q. Lee. A scholar is included among the top collaborators of E. Q. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Q. Lee. E. Q. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Lee, E. Q., David A. Reardon, D. Schiff, et al.. (2015). Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma. Neuro-Oncology. 17(6). 862–867. 103 indexed citations

2.

Schiff, D., E. Q. Lee, Lakshmi Nayak, et al.. (2014). Medical management of brain tumors and the sequelae of treatment. Neuro-Oncology. 17(4). 488–504. 99 indexed citations

3.

Aizer, Ayal A., Nils D. Arvold, Paul J. Catalano, et al.. (2014). Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma. Neuro-Oncology. 16(11). 1547–1553. 84 indexed citations

4.

Rahman, Rifaquat, Andrew D. Norden, David A. Reardon, et al.. (2014). Retrospective study of carmustine or lomustine with bevacizumab in recurrent glioblastoma patients who have failed prior bevacizumab. Neuro-Oncology. 16(11). 1523–1529. 19 indexed citations

5.

Wen, Patrick Y., W.K. Alfred Yung, Ingo K. Mellinghoff, et al.. (2014). PHASE II TRIAL OF THE PHOSPHATIDYINOSITOL-3 KINASE (PI3K) INHIBITOR BUPARLISIB (BKM120) IN RECURRENT GLIOBLASTOMA CONDUCTED BY THE IVY FOUNDATION EARLY PHASE CLINICAL TRIALS CONSORTIUM. Neuro-Oncology. 16(suppl 3). iii47–iii47. 8 indexed citations

6.

Lee, E. Q., John G. Kuhn, Kathleen R. Lamborn, et al.. (2012). Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02. Neuro-Oncology. 14(12). 1511–1518. 90 indexed citations

7.

Wen, Patrick Y., E. Q. Lee, David A. Reardon, Keith L. Ligon, & W.K. Alfred Yung. (2012). Current clinical development of PI3K pathway inhibitors in glioblastoma. Neuro-Oncology. 14(7). 819–829. 109 indexed citations

8.

Drappatz, Jan, E. Q. Lee, Samantha N. Hammond, et al.. (2011). Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma. Journal of Neuro-Oncology. 107(1). 133–138. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact